Cargando…
Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice
Malaria is caused by infection with Plasmodium parasites and results in significant health and economic impacts. Malaria eradication is hampered by parasite resistance to current drugs and the lack of a widely effective vaccine. Compounds that target epigenetic regulatory proteins, such as histone d...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463797/ https://www.ncbi.nlm.nih.gov/pubmed/34560571 http://dx.doi.org/10.1016/j.ijpddr.2021.08.006 |
_version_ | 1784572473141886976 |
---|---|
author | Chua, Ming Jang Tng, Jiahui Hesping, Eva Fisher, Gillian M. Goodman, Christopher D. Skinner-Adams, Tina Do, Darren Lucke, Andrew J. Reid, Robert C. Fairlie, David P. Andrews, Katherine T. |
author_facet | Chua, Ming Jang Tng, Jiahui Hesping, Eva Fisher, Gillian M. Goodman, Christopher D. Skinner-Adams, Tina Do, Darren Lucke, Andrew J. Reid, Robert C. Fairlie, David P. Andrews, Katherine T. |
author_sort | Chua, Ming Jang |
collection | PubMed |
description | Malaria is caused by infection with Plasmodium parasites and results in significant health and economic impacts. Malaria eradication is hampered by parasite resistance to current drugs and the lack of a widely effective vaccine. Compounds that target epigenetic regulatory proteins, such as histone deacetylases (HDACs), may lead to new therapeutic agents with a different mechanism of action, thereby avoiding resistance mechanisms to current antimalarial drugs. The anticancer HDAC inhibitor AR-42, as its racemate (rac-AR-42), and 36 analogues were investigated for in vitro activity against P. falciparum. Rac-AR-42 and selected compounds were assessed for cytotoxicity against human cells, histone hyperacetylation, human HDAC1 inhibition and oral activity in a murine malaria model. Rac-AR-42 was tested for ex vivo asexual and in vitro exoerythrocytic stage activity against P. berghei murine malaria parasites. Rac-AR-42 and 13 achiral analogues were potent inhibitors of asexual intraerythrocytic stage P. falciparum 3D7 growth in vitro (IC(50) 5–50 nM), with four of these compounds having >50-fold selectivity for P. falciparum versus human cells (selectivity index 56–118). Rac-AR-42 induced in situ hyperacetylation of P. falciparum histone H4, consistent with PfHDAC(s) inhibition. Furthermore, rac-AR-42 potently inhibited P. berghei infected erythrocyte growth ex vivo (IC(50) 40 nM) and P. berghei exoerythrocytic forms in hepatocytes (IC(50) 1 nM). Oral administration of rac-AR-42 and two achiral analogues inhibited P. berghei growth in mice, with rac-AR-42 (50 mg/kg/day single dose for four days) curing all infections. These findings demonstrate curative properties for HDAC inhibitors in the oral treatment of experimental mouse malaria. |
format | Online Article Text |
id | pubmed-8463797 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-84637972021-10-01 Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice Chua, Ming Jang Tng, Jiahui Hesping, Eva Fisher, Gillian M. Goodman, Christopher D. Skinner-Adams, Tina Do, Darren Lucke, Andrew J. Reid, Robert C. Fairlie, David P. Andrews, Katherine T. Int J Parasitol Drugs Drug Resist Regular article Malaria is caused by infection with Plasmodium parasites and results in significant health and economic impacts. Malaria eradication is hampered by parasite resistance to current drugs and the lack of a widely effective vaccine. Compounds that target epigenetic regulatory proteins, such as histone deacetylases (HDACs), may lead to new therapeutic agents with a different mechanism of action, thereby avoiding resistance mechanisms to current antimalarial drugs. The anticancer HDAC inhibitor AR-42, as its racemate (rac-AR-42), and 36 analogues were investigated for in vitro activity against P. falciparum. Rac-AR-42 and selected compounds were assessed for cytotoxicity against human cells, histone hyperacetylation, human HDAC1 inhibition and oral activity in a murine malaria model. Rac-AR-42 was tested for ex vivo asexual and in vitro exoerythrocytic stage activity against P. berghei murine malaria parasites. Rac-AR-42 and 13 achiral analogues were potent inhibitors of asexual intraerythrocytic stage P. falciparum 3D7 growth in vitro (IC(50) 5–50 nM), with four of these compounds having >50-fold selectivity for P. falciparum versus human cells (selectivity index 56–118). Rac-AR-42 induced in situ hyperacetylation of P. falciparum histone H4, consistent with PfHDAC(s) inhibition. Furthermore, rac-AR-42 potently inhibited P. berghei infected erythrocyte growth ex vivo (IC(50) 40 nM) and P. berghei exoerythrocytic forms in hepatocytes (IC(50) 1 nM). Oral administration of rac-AR-42 and two achiral analogues inhibited P. berghei growth in mice, with rac-AR-42 (50 mg/kg/day single dose for four days) curing all infections. These findings demonstrate curative properties for HDAC inhibitors in the oral treatment of experimental mouse malaria. Elsevier 2021-08-23 /pmc/articles/PMC8463797/ /pubmed/34560571 http://dx.doi.org/10.1016/j.ijpddr.2021.08.006 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Regular article Chua, Ming Jang Tng, Jiahui Hesping, Eva Fisher, Gillian M. Goodman, Christopher D. Skinner-Adams, Tina Do, Darren Lucke, Andrew J. Reid, Robert C. Fairlie, David P. Andrews, Katherine T. Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice |
title | Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice |
title_full | Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice |
title_fullStr | Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice |
title_full_unstemmed | Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice |
title_short | Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice |
title_sort | histone deacetylase inhibitor ar-42 and achiral analogues kill malaria parasites in vitro and in mice |
topic | Regular article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463797/ https://www.ncbi.nlm.nih.gov/pubmed/34560571 http://dx.doi.org/10.1016/j.ijpddr.2021.08.006 |
work_keys_str_mv | AT chuamingjang histonedeacetylaseinhibitorar42andachiralanalogueskillmalariaparasitesinvitroandinmice AT tngjiahui histonedeacetylaseinhibitorar42andachiralanalogueskillmalariaparasitesinvitroandinmice AT hespingeva histonedeacetylaseinhibitorar42andachiralanalogueskillmalariaparasitesinvitroandinmice AT fishergillianm histonedeacetylaseinhibitorar42andachiralanalogueskillmalariaparasitesinvitroandinmice AT goodmanchristopherd histonedeacetylaseinhibitorar42andachiralanalogueskillmalariaparasitesinvitroandinmice AT skinneradamstina histonedeacetylaseinhibitorar42andachiralanalogueskillmalariaparasitesinvitroandinmice AT dodarren histonedeacetylaseinhibitorar42andachiralanalogueskillmalariaparasitesinvitroandinmice AT luckeandrewj histonedeacetylaseinhibitorar42andachiralanalogueskillmalariaparasitesinvitroandinmice AT reidrobertc histonedeacetylaseinhibitorar42andachiralanalogueskillmalariaparasitesinvitroandinmice AT fairliedavidp histonedeacetylaseinhibitorar42andachiralanalogueskillmalariaparasitesinvitroandinmice AT andrewskatherinet histonedeacetylaseinhibitorar42andachiralanalogueskillmalariaparasitesinvitroandinmice |